Conditions

What factors affect adherence for our young patients? 

Minimization of secondary diabetic complications from early glycemic control in type 2 diabetes patients. 

Can cholesteryl ester transfer protein inhibitors reduce incident type 2 diabetes? 

Patients with prediabetes show differences in human host markers and gut microbiome compared to healthy patients. 

An old axiom says that good things may come in small packages – can the same be said for exercise? HIIT exercises take minimal time but appear to provide benefits in patients with type 1 diabetes.

Adults who have diabetes are two times more likely to die from heart disease and stroke, and younger people with diabetes are at risk of earlier heart disease. 

Patients with type 1 diabetes should not be excluded when considering statin therapy.

Are patients on board with new insulin delivery and glucose monitoring technology?

The MAG1C interventional study was a single-center, 26-week, phase 2a, to look at how Exenatide might benefit patients with type 1 diabetes. 

Current studies are showing that micro and macro complications begin at prediabetes.